Discovery and optimization of a series of liver X receptor antagonists

被引：16

作者：

Jiao, XianYun ^{[1
]}

Kopecky, David J. ^{[1
]}

Fisher, Ben ^{[1
]}

Piper, Derek E. ^{[2
]}

Labelle, Marc ^{[1
]}

McKendry, Sharon ^{[1
]}

Harrison, Martin ^{[2
]}

Jones, Stuart ^{[2
]}

Jaen, Juan ^{[1
]}

Shiau, Andrew K. ^{[3
]}

Escaron, Patrick ^{[3
]}

Danao, Jean ^{[3
]}

Chai, Anne ^{[3
]}

Coward, Peter ^{[3
]}

Kayser, Frank ^{[1
]}

机构：

[1] Amgen Inc, Dept Med Chem, San Francisco, CA 94080 USA

[2] Amgen Inc, Dept Mol Struct & Characterizat, San Francisco, CA 94080 USA

[3] Amgen Inc, Dept Metab Disorders, San Francisco, CA 94080 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 18期

关键词：

LXR alpha/beta; Antagonist; GAL4 reporter gene assay; mSREBP-1c reporter; Conversion; LXR-ALPHA; DEFICIENT MICE; CHOLESTEROL; GENE; LIGAND; BETA; AGONISTS; ATHEROSCLEROSIS; MODULATORS; PROMOTER;

D O I：

10.1016/j.bmcl.2012.07.048

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The present report describes our efforts to convert an existing LXR agonist into an LXR antagonist using a structure-based approach. A series of benzenesulfonamides was synthesized based on structural modification of a known LXR agonist and was determined to be potent dual liver X receptor (LXR alpha/beta) ligands. Herein we report the identification of compound 54 as the first reported LXR antagonist that is suitable for pharmacological in vivo evaluation in rodents. (C) 2012 Published by Elsevier Ltd.

引用

页码：5966 / 5970

页数：5

共 50 条

[41] The discovery of highly potent CGRP receptor antagonists
Stump, Craig A.
Bell, Ian M.
Bednar, Rodney A.
Bruno, Joseph G.
Fay, John F.
Gallicchio, Steven N.
Johnston, Victor K.
Moore, Eric L.
Mosser, Scott D.
Quigley, Amy G.
Salvatore, Christopher A.
Theberge, Cory R.
Zartman, C. Blair
Zhang, Xu-Fang
Kane, Stefanie A.
Graham, Samuel L.
Vacca, Joseph P.
Williams, Theresa M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (01) : 214 - 217
[42] Discovery and therapeutic potential of kinin receptor antagonists
Whalley, Eric T.
Figueroa, Carlos D.
Gera, Lajos
Bhoola, Kanti D.
EXPERT OPINION ON DRUG DISCOVERY, 2012, 7 (12) : 1129 - 1148
[43] Chemokine receptor antagonists from discovery to the clinic
Horuk, R
LEUCOCYTE TRAFFICKING: THE ROLE OF FUCOSYLTRANSFERASES AND SELECTINS, 2004, 44 : 169 - 190
[44] Discovery of a new class of ghrelin receptor antagonists
Mihalic, Jeffrey T.
Kim, Yong-Jae
Lizarzaburu, Mike
Chen, Xiaoqi
Deignan, Jeff
Wanska, Malgorzata
Yu, Ming
Fu, Jiasheng
Chen, Xi
Zhang, Alex
Connors, Richard
Liang, Lingming
Lindstrom, Michelle
Ma, Ji
Tang, Liang
Dai, Kang
Li, Leping
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (05) : 2046 - 2051
[45] Discovery and characterization of selective orexin receptor antagonists
Shireman, Brock T.
Bonaventure, Pascal
Letavic, Michael A.
Lebold, Terry A.
Dugovic, Christine
Lord, Brian
Morton, Kirsten L.
Nepomuceno, Diane
Shelton, Jonathan
Aluisio, Leah
Fraser, Ian
Acton, Paul
Johnson, Phil
Shekhar, Anantha
Lovenberg, Timothy W.
Carruthers, Nicholas I.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[46] Discovery, evaluation, and characterization of nuclear receptor antagonists
Turner, BA
Grover, GS
Lee, PH
Parker, CN
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 449A - 449A
[47] Recent discovery and development of endothelin receptor antagonists
Wu, CD
EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (11) : 1653 - 1668
[48] Discovery of novel α7 nicotinic receptor antagonists
Peng, Youyi
Zhang, Qiang
Snyder, Gretchen L.
Zhu, Hongwen
Yao, Wei
Tomesch, John
Papke, Roger L.
O'Callaghan, James P.
Welsh, William J.
Wennogle, Lawrence P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (16) : 4825 - 4830
[49] Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist
Zheng, Yajun
Zhuang, Linghang
Fan, Kristi Yi
Tice, Colin M.
Zhao, Wei
Dong, Chengguo
Lotesta, Stephen D.
Leftheris, Katerina
Lindblom, Peter R.
Liu, Zhijie
Shimada, Jun
Noto, Paul B.
Meng, Shi
Hardy, Andrew
Howard, Lamont
Krosky, Paula
Guo, Joan
Lipinski, Kerri
Kandpal, Geeta
Bukhtiyarov, Yuri
Zhao, Yi
Lala, Deepak
Van Orden, Rebecca
Zhou, Jing
Chen, Guozhou
Wu, Zhongren
McKeever, Brian M.
McGeehan, Gerard M.
Gregg, Richard E.
Claremon, David A.
Singh, Suresh B.
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (07) : 3264 - 3271
[50] Discovery of novel liver X receptor inverse agonists as lipogenesis inhibitors
Chen, Ziyang
Chen, Hao
Zhang, Zizhen
Ding, Peng
Yan, Xin
Li, Yanwen
Zhang, Songxuan
Gu, Qiong
Zhou, Huihao
Xu, Jun
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 206

← 1 2 3 4 5 →